Medigus debuts world's smallest video camera; Boston Sci's Elliot gets feisty;

> Medigus has developed the world's smallest video camera--just 0.99 mm in diameter. These miniature cameras are manufactured from materials suitable for human medical procedures and are designed specifically for small-diameter disposable endoscopic devices. Medical fields in which such tools are required include cardiology, orthopedics, gastroenterology, gynecology, otolaryngology, bronchoscopy and robotic surgery. Medigus release

> Boston Scientific CEO Ray Elliot got feisty Monday. Speaking at an investor's conference two days prior to the annual Heart Rhythm Society meeting, Elliot dismissed two of his biggest rivals' new cardiac rhythm management products. "Protecta is a catch-up product," Elliot said. "We've had that technology since 2008. I know Medtronic wouldn't agree, but they'd be wrong." Elliot then took aim at St. Jude, calling that company's new lead "99 percent hype." Story

> BioCurex's OncoPet Diagnostics unit has entered into a distribution agreement for its companion animal OncoPet RECAF cancer detection test with Success Vision Biotek of Taipei, Taiwan. The agreement is exclusive for the distribution of companion animal RECAF tests throughout Taiwan. BioCurex release

> Less than a year after launching its Medical Accelerator, the University of Utah is graduating its first research-based company from the facility. The company is Catheter Connections, which produces an infection-control device that protects patients from infection during intravenous infusion therapy. The device has the potential to prevent thousands of infections and deaths caused by contaminated IV catheters and IV administration sets in hospitals in the U.S. University of Utah release

> Cancer molecular diagnostics firm MDxHealth and partner NovioGendix have received a $1.1 million grant from the Eurotrans-Bio initiative to support development of a DNA methylation biomarker-based cancer diagnostic for predicting bladder cancer invasion into the muscle. News

> Immunetics has been awarded a $2.4 million, three-year Phase II SBIR grant by the National Institute of Allergy and Infectious Diseases, a division of the NIH, to support clinical trials of the company's new confirmatory test for Chagas' disease, a serious and potentially fatal parasitic infection. Immunetics release

> Boston Scientific has announced CE Mark approval and first use in Europe of its Blazer open-irrigated catheter, the company's latest radiofrequency ablation catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. Boston Scientific release

> Delcath Systems has added another former AngioDynamics executive to its senior management team. Harold Mapes has been appointed as Delcath's executive VP of global operations. Story

> Dr. Danny Rabah, a U.S.-trained urologist in Riyadh, Saudi Arabia, has begun using The Spanner prostatic stent from AbbeyMoor Medical in place of Foley catheters for some patients. Both devices improve urinary voiding when swelling of the prostate impairs normal urination, but unlike a Foley catheter, which collects urine externally, The Spanner facilitates normal urination. AbbeyMoore Medical release

And Finally... The state Board of Medical Examiners penalized three orthopedic surgeons for failing to disclose their financial interest in a medical device while participating in clinical trials, Attorney General Paula Dow has announced. Report